Dendreon Corp (DNDN)
$27.20
-0.34 (-1.23%)
| CAPS Rating |
|
|---|---|
| Open | $0.00 |
| Previous Close | $27.54 |
| Daily Range | $27.08 - $27.66 |
| 52-Week Range | $2.55 - $30.42 |
| Market Cap | $3.15B |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,476,060 |
| Average Daily Volume | 2,439,000 |
DNDN
VS S&P 500 (SPY)
How do you think DNDN will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
DNDN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
DNDN News and Commentary
- UPDATE 1-FDA says Dendreon's drug application is complete – Reuters
- This Is Why You're Not Making Money in the Market – The Motley Fool
- UPDATE 1-Dendreon Q3 loss wider than expected on higher expenses – Reuters
- 7 Reasons Not to Worry This Week – The Motley Fool
- 5 Cold Stocks Heating Up – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- UPDATE 1-Dendreon files in U.S. for prostate cancer vaccine – Reuters
- The World's Scariest Stocks – The Motley Fool
- Dear Senator Hagan, – Blog at The Motley Fool
- Health-Care Reform: You Can't Have It Both Ways – The Motley Fool
- UPDATE 1-Dendreon adds two industry heavyweights to board – Reuters
- Buy Before It's Too Late – The Motley Fool
- This Stock Has Tremendous Upside – The Motley Fool
- Dendreon soon to be part of a major pharma – Blog at The Motley Fool
- Rocket Stock or Dud? – The Motley Fool
- Your Best Chance to Profit in 2009 – The Motley Fool
- Dendreon Struts Its Stuff – The Motley Fool
- UPDATE 1-Dendreon to seek Provenge approval in November – Reuters
- It's Already Worse Than the Depression – The Motley Fool
- Does Sirius Deserve Your Love? – The Motley Fool
RSS Headlines
Fool UK
